The often contentious task force has finally released some ideas for the 2017 session, limiting the amount consumers can pay to $100 a month and limiting insurer costs to $5,000 per drug, per patient a year. The proposal infuriated PhRMA, but in the months of discussion, Rep. Rob Nosse said the industry did not introduce a single proposal for making their products more affordable.
Oct 28, 2016